-
EP2170886
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2170886
| EP2170886 - 9H-pyrimido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9H-1,3,6,9-tetraaza-fluorenes as CHK1 kinase function inhibitors [Right-click to bookmark this link] | |||
| Former [2010/14] | 9H-PYRIMIDO[4,5-B]INDOLES, 9H-PYRIDO[4',3':4,5]PYRROLO[2,3-D]PYRIDINES, AND 9H-1,3,6,9-TETRAAZA-FLUORENES AS CHK1 KINASE FUNCTION INHIBITORS | ||
| [2011/39] | Status | The application is deemed to be withdrawn Status updated on 29.06.2012 Database last updated on 29.10.2024 | Most recent event Tooltip | 29.06.2012 | Application deemed to be withdrawn | published on 01.08.2012 [2012/31] | Applicant(s) | For all designated states Cancer Research Technology Limited Angel Building 407 St. John Street London EC1V 4AD / GB | [2011/29] |
| Former [2010/14] | For all designated states Cancer Research Technology Limited Sardinia House, Sardina Street, London GreaterLondon WC2A 3NL / GB | Inventor(s) | 01 /
COLLINS, Ian The Institute of Cancer Research 15 Cotswold Road Sutton Surrey SM2 5NG / GB | 02 /
READER, John, Charles Sareum Ltd. 2 Iconix Park Cambridge Cambridgeshire CB22 3EG / GB | 03 /
KLAIR, Suki Sareum Ltd. 2 Iconix Park Cambridge Cambridgeshire CB22 3EG / GB | 04 /
SCANLON, Jane Sareum Ltd. 2 Iconix Park Cambridge Cambridgeshire CB22 3EG / GB | 05 /
ADDISON, Glynn Sareum Ltd. 2 Iconix Park Cambridge Cambridgeshire CB22 3EG / GB | 06 /
CHERRY, Michael Sareum Ltd. 2 Iconix Park Cambridge Cambridgeshire CB22 3EG / GB | [2010/14] | Representative(s) | Wytenburg, Wilhelmus Johannes, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
| Former [2010/14] | Wytenburg, Wilhelmus Johannes, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | Application number, filing date | 08775809.0 | 01.07.2008 | [2010/14] | WO2008GB02259 | Priority number, date | US20070947540P | 02.07.2007 Original published format: US 947540 P | [2010/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009004329 | Date: | 08.01.2009 | Language: | EN | [2009/02] | Type: | A1 Application with search report | No.: | EP2170886 | Date: | 07.04.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.01.2009 takes the place of the publication of the European patent application. | [2010/14] | Search report(s) | International search report - published on: | EP | 08.01.2009 | Classification | IPC: | C07D471/14, A61K31/519, C07D487/04, C07D487/14, A61P35/00 | [2010/14] | CPC: |
C07D471/14 (EP,US);
A61P35/00 (EP);
C07D487/04 (EP,US);
C07D487/14 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/14] | Title | German: | 9H-Pyrimido[4',3':4,5]pyrrolo[2,3-d]pyridine und 9H-1,3,6,9-tetraazafluorene als Inhibitoren der Funktion von CHK1-kinase | [2011/39] | English: | 9H-pyrimido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9H-1,3,6,9-tetraaza-fluorenes as CHK1 kinase function inhibitors | [2011/39] | French: | 9H-pyrimido[4',3':4,5]pyrrolo[2,3-d]pyridines, et 9H-1,3,6,9-tétraaza-fluorènes en tant qu'inhibiteurs de la fonction kinase CHK1 | [2011/39] |
| Former [2010/14] | 9H-PYRIMIDO[4,5-B]INDOLE, 9H-PYRIDO[4ý,3ý:4,5]PYRROLO[2,3-D]PYRIDINE UND 9H-1,3,6,9-TETRAAZAFLUORENE ALS INHIBITOREN DER FUNKTION VON CHK1-KINASE | ||
| Former [2010/14] | 9H-PYRIMIDO[4,5-B]INDOLES, 9H-PYRIDO[4',3':4,5]PYRROLO[2,3-D]PYRIDINES, AND 9H-1,3,6,9-TETRAAZA-FLUORENES AS CHK1 KINASE FUNCTION INHIBITORS | ||
| Former [2010/14] | 9H-PYRIMIDO[4,5-B]INDOLES, 9H-PYRIDO[4',3':4,5]PYRROLO[2,3-D]PYRIDINES, ET 9H-1,3,6,9-TÉTRAAZA-FLUORÈNES EN TANT QU'INHIBITEURS DE LA FONCTION KINASE CHK1 | Entry into regional phase | 25.01.2010 | National basic fee paid | 25.01.2010 | Designation fee(s) paid | 25.01.2010 | Examination fee paid | Examination procedure | 25.01.2010 | Amendment by applicant (claims and/or description) | 25.01.2010 | Examination requested [2010/14] | 16.09.2010 | Despatch of a communication from the examining division (Time limit: M06) | 13.07.2011 | Reply to a communication from the examining division | 23.09.2011 | Communication of intention to grant the patent | 04.02.2012 | Application deemed to be withdrawn, date of legal effect [2012/31] | 14.03.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2012/31] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.09.2010 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 13.07.2011 | Request for further processing filed | 13.07.2011 | Full payment received (date of receipt of payment) Request granted | 25.08.2011 | Decision despatched | Fees paid | Renewal fee | 26.01.2011 | Renewal fee patent year 03 | 05.01.2012 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.07.2010 | 03 M06 Fee paid on 26.01.2011 | 31.07.2011 | 04 M06 Fee paid on 05.01.2012 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2007041712 (SCHERING CORP [US], et al); | [A]WO2006116733 (SUPERGEN INC [US], et al) [A] * the whole document *; | [A]WO2005037825 (UNIV ARIZONA [US], et al) [A] * example -; claim - * |